Intraperitoneal Lymphokine-Activated Killer Cell/Interleukin-2 Therapy in Patients With Intra- abdominal Cancer: Immunologic Considerations

Walter J. Urba, Dan L. Longo, Ronald G. Steis et al.|JNCI Journal of the National Cancer Institute|1989

Cited by 51